News
Novartis is thriving with double-digit growth, driven by key drugs in oncology, cardiology, immunology, and neurology. See ...
2d
MarketBeat on MSN3 Robotics Stocks That Could Benefit From U.S. Manufacturing BoomWith the latest round of tariffs from the Trump administration in early April 2025, investors and business owners alike are ...
“Reciprocal” tariffs, as well as additional tariffs on China, are due to take effect at midnight EST.
Bank earnings arriving as trade war intensifies, Tesla price target slashed amid Musk ‘brand crisis tornado,’ and more news ...
"I wanted to create an improved banking card with added security features like real-time location tracking, geofencing alerts, biometric security, and remote card locking," said an ...
A federal judge ruled in favor of Merck in litigation accusing it of concealing ... 2025 Citigroup wins appeal against military personnel over credit card rates Citigroup can force military ...
Merck & Co. Inc. closed 41.19% below its 52-week high of $134.63, which the company reached on June 25th.
Lusaka [Zambia] / Mumbai (Maharashtra) [India], April 7: Merck Foundation, the philanthropic arm of Merck KGaA Germany marks 'World Health Day' 2025 in partnership with Africa's First Ladies who ...
Goldman Sachs analyst Asad Haider assumed coverage of Merck (MRK) with a Buy rating and price target of $103, down from $129. Following the ...
A Jan. 13 decision out of the U.S. Court of Appeals for the Sixth Circuit is one more nail in the coffin of "silent cyber." ...
Leaders at Merck & Co. Inc. are facing a new derivative shareholder lawsuit over allegations that they made misleading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results